BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20651355)

  • 1. Clioquinol independently targets NF-kappaB and lysosome pathways in human cancer cells.
    Yu H; Lou JR; Ding WQ
    Anticancer Res; 2010 Jun; 30(6):2087-92. PubMed ID: 20651355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiosensitization of clioquinol and zinc in human cancer cell lines.
    Lu S; Ke Y; Wu C; Zhong Y; Xie C; Zhou Y; Zhou F; Yu H
    BMC Cancer; 2018 Apr; 18(1):448. PubMed ID: 29678153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clioquinol targets zinc to lysosomes in human cancer cells.
    Yu H; Zhou Y; Lind SE; Ding WQ
    Biochem J; 2009 Jan; 417(1):133-9. PubMed ID: 18764784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human immunodeficiency virus (HIV)-1 protease inhibitor saquinavir inhibits proteasome function and causes apoptosis and radiosensitization in non-HIV-associated human cancer cells.
    Pajonk F; Himmelsbach J; Riess K; Sommer A; McBride WH
    Cancer Res; 2002 Sep; 62(18):5230-5. PubMed ID: 12234989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts.
    Chen D; Cui QC; Yang H; Barrea RA; Sarkar FH; Sheng S; Yan B; Reddy GP; Dou QP
    Cancer Res; 2007 Feb; 67(4):1636-44. PubMed ID: 17308104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acacetin (5,7-dihydroxy-4'-methoxyflavone) exhibits in vitro and in vivo anticancer activity through the suppression of NF-κB/Akt signaling in prostate cancer cells.
    Kim HR; Park CG; Jung JY
    Int J Mol Med; 2014 Feb; 33(2):317-24. PubMed ID: 24285354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverse effects of zinc on NF-kappaB and AP-1 transcription factors: implications for prostate cancer progression.
    Uzzo RG; Crispen PL; Golovine K; Makhov P; Horwitz EM; Kolenko VM
    Carcinogenesis; 2006 Oct; 27(10):1980-90. PubMed ID: 16606632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of nuclear factor-kappaB contributes to induction of death receptors and apoptosis by the synthetic retinoid CD437 in DU145 human prostate cancer cells.
    Jin F; Liu X; Zhou Z; Yue P; Lotan R; Khuri FR; Chung LW; Sun SY
    Cancer Res; 2005 Jul; 65(14):6354-63. PubMed ID: 16024638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione; C21H20O6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppressing nuclear factor-kappaB via inhibition of the prosurvival Akt signaling pathway.
    Deeb D; Jiang H; Gao X; Al-Holou S; Danyluk AL; Dulchavsky SA; Gautam SC
    J Pharmacol Exp Ther; 2007 May; 321(2):616-25. PubMed ID: 17289836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of nuclear factor-kappaB and proteasome by dithiocarbamate complexes with metals.
    Cvek B; Dvorak Z
    Curr Pharm Des; 2007; 13(30):3155-67. PubMed ID: 17979756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasome inhibitors up-regulate haem oxygenase-1 gene expression: requirement of p38 MAPK (mitogen-activated protein kinase) activation but not of NF-kappaB (nuclear factor kappaB) inhibition.
    Wu WT; Chi KH; Ho FM; Tsao WC; Lin WW
    Biochem J; 2004 May; 379(Pt 3):587-93. PubMed ID: 14731112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin, both histone deacetylase and p300/CBP-specific inhibitor, represses the activity of nuclear factor kappa B and Notch 1 in Raji cells.
    Chen Y; Shu W; Chen W; Wu Q; Liu H; Cui G
    Basic Clin Pharmacol Toxicol; 2007 Dec; 101(6):427-33. PubMed ID: 17927689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-kappaB.
    Kim SM; Lee SY; Cho JS; Son SM; Choi SS; Yun YP; Yoo HS; Yoon DY; Oh KW; Han SB; Hong JT
    Eur J Pharmacol; 2010 Apr; 631(1-3):1-9. PubMed ID: 20056115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-kappaB inhibition through proteasome inhibition or IKKbeta blockade increases the susceptibility of melanoma cells to cytostatic treatment through distinct pathways.
    Amschler K; Schön MP; Pletz N; Wallbrecht K; Erpenbeck L; Schön M
    J Invest Dermatol; 2010 Apr; 130(4):1073-86. PubMed ID: 19940859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SRS06, a new semisynthetic andrographolide derivative with improved anticancer potency and selectivity, inhibits nuclear factor-κB nuclear binding in the A549 non-small cell lung cancer cell line.
    Lim JC; Jeyaraj EJ; Sagineedu SR; Wong WS; Stanslas J
    Pharmacology; 2015; 95(1-2):70-7. PubMed ID: 25613753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway.
    Li Y; Sarkar FH
    Clin Cancer Res; 2002 Jul; 8(7):2369-77. PubMed ID: 12114442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells.
    Li Y; Ahmed F; Ali S; Philip PA; Kucuk O; Sarkar FH
    Cancer Res; 2005 Aug; 65(15):6934-42. PubMed ID: 16061678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal bovine serum requirement for pyrrolidine dithiocarbamate-induced apoptotic cell death of MCF-7 breast tumor cells.
    Oh DH; Bang JS; Choi HM; Yang HI; Yoo MC; Kim KS
    Eur J Pharmacol; 2010 Dec; 649(1-3):135-9. PubMed ID: 20868670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clioquinol induces cytoplasmic clearance of the X-linked inhibitor of apoptosis protein (XIAP): therapeutic indication for prostate cancer.
    Cater MA; Haupt Y
    Biochem J; 2011 Jun; 436(2):481-91. PubMed ID: 21426304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDDO-Me inhibits proliferation, induces apoptosis, down-regulates Akt, mTOR, NF-kappaB and NF-kappaB-regulated antiapoptotic and proangiogenic proteins in TRAMP prostate cancer cells.
    Deeb D; Gao X; Dulchavsky SA; Gautam SC
    J Exp Ther Oncol; 2008; 7(1):31-9. PubMed ID: 18472640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.